magistrsko delo
    	
    Povzetek
 
Celice CHO sože vrsto let vodilni ekspresijski sistem za proizvodnjo bioloških zdravil. Trenutni razvoj celičnih linij temelji na naključni integraciji ekspresijskega vektorja v genom celic CHO, s čimer pridobimo klone, ki se med sabo zelo razlikujejo tako v stopnji kot tudi stabilnosti produkcije proteinov. Za razvoj visoko producirajoče celične linije, je tako potrebno generirati in presejati ogromno število klonov. Predpostavili smo, da bi s tarčno integracijo mAb ekspresijskega vektorja v regije genoma celic CHO, ki se nahajajo blizu  super-ojačevalcev določenih z  metodo  ATAC-seq, lažje in hitreje razvili visoko producirajočo celično linijo. V okviru magistrske naloge smo želeli vzpostaviti enostaven in učinkovit način tarčne integracije. Za  vstavitev  lineariziranega  mAb  ekspresijskega vektorja v tarčno mesto smo izkoristili popravljalni mehanizem spajanja nehomolognih koncev, ki sodeluje pri popravilu dvojnega preloma DNA. Prelom dvojne vijačnice smo v  celicah tarčno sprožili z uporabo orodja za  urejanje  genoma. Z  razvito  metodo  smo dosegli učinkovitost tarčne integracije med 3 in 11 %, odvisno od učinkovitosti delovanja sistema za urejanje genoma in tarčne regije. V drugem delu magistrske naloge smo pri klonih s tarčno integriranim ekspresijskim vektorjem ovrednotili vpliv super-ojačevalcev na izražanje heterolognih genov ter na produktivnost posameznih klonov. Pokazali smo, da s tarčno integracijo dosežemo 1,7-krat višjo stopnjo izražanja heterolognih genov ter 1,5-krat višjo  specifično  produktivnost. Z  analizo,v  kateri  smo  ugotavljali  stopnjo izražanja heterolognega  gena  na  posamezno kopijo  ekspresijskega  vektorja pa smo ugotovili, da med kloni s tarčno in naključno integracijo ni statistično pomembne razlike. Poleg  tega  smo  pokazali, da  z  metodo tarčne  integracije na  osnovi popravljalnega mehanizma spajanja nehomolognih koncev v genom celic CHO integriramo večje število kopij heterolognega  gena kot z naključno integracijo. V  okviru  magistrske  naloge  smo torej uspeli razviti način za pripravo celičnih linij z izboljšano produktivnostjo.
    Ključne besede
 
celice CHO;ovarijske celice kitajskega hrčka;tarčna integracija;NHEJ;super-ojačevalec;magistrska dela;
    Podatki
 
    
        
            | Jezik: | Slovenski jezik | 
        
        
            | Leto izida: | 2020 | 
            
        
        
            | Tipologija: | 2.09 - Magistrsko delo | 
            
        
            | Organizacija: | UL FKKT - Fakulteta za kemijo in kemijsko tehnologijo | 
        
            | Založnik: | [P. Vivod] | 
   
        
            | UDK: | 577.21(043.2) | 
   
        
        
            | COBISS: | 1538524611   | 
        
        
  
        
            | Št. ogledov: | 584 | 
        
        
            | Št. prenosov: | 46 | 
        
        
            | Ocena: | 0 (0 glasov) | 
        
            | Metapodatki: |                       | 
    
    
    Ostali podatki
 
    
        
            | Sekundarni jezik: | Angleški jezik | 
        
        
            | Sekundarni naslov: | Targeted integration of heterologous monoclonal antibody genes into the genome of CHO cells | 
        
        
        
            | Sekundarni povzetek: | For many years, CHO cells have been the leading expression system for the production of  biological  drugs.  The  current  cell  line  development process is  based  on  the  random integration  of  the  expression  vector  into  the  genome  of  CHO  cells,  which  leads to  the generation  of clones  that  differ significantly in  both  the  rate  and  stability  of  protein production.  In order to develop a highly producing cell line, it is necessary  to generate and  screen  a  huge  number  of  clones.  We  hypothesized  that  targeted integration  of  the mAb expression vector into regions of the genome located close to the super-enhancers, determined by the ATAC-seq method, would allow easier and more rapid development of a  high-producing  cell  line. As  part  of  the  master's  thesis,  we  wanted  to  establish  a simple and effective targeted integration approach. For the insertion of a linearized mAb expression vector into the target site, we utilized a DNA double-strand break caused by genome editing tool, which is repaired by the non-homologous end joining(NHEJ). With the  developed  method,  we  achieved between  3  and  11  % efficiency  of  targeted integration, depending on the activity of the genome editing tool and the target region. In the  second  part  of  the  thesis,  we  evaluated  the  influence  of  super-enhancers  on  the expression of heterologous genes and the productivity of individual clones with a target-integrated mAb expression vector. Targeted integration has been shown to increasethe expression  of  heterologous  genes and specific  productivity of  generated  clones  by 1,7-foldand 1,5-fold,  respectively, when  compared to random integration. However, when analyzing the mRNA expression levels per copy of the heterologous gene, no statistically significant difference between clones with targeted and random integration was observed. Furthermore, we  have  shown, for  the  first  time,that when using  NHEJ based targeted integration of expression vector into the CHO cell genome, more copies of heterologous genes are introduced into the genome compared to random integration, leading to higher specific  productivity. In summary, we  developed a targeted  integration  approach  for generating production cell lines with improved productivity. | 
        
        
            | Sekundarne ključne besede: | targeted integration;NHEJ;super-enhancers;CHO cells; | 
        
            
        
            | Vrsta dela (COBISS): | Magistrsko delo/naloga | 
        
        
            | Študijski program: | 1000377 | 
        
           
        
           
        
           
        
            | Konec prepovedi (OpenAIRE): | 2021-01-29 | 
        
           
        
            | Komentar na gradivo: | Univ. v Ljubljani, Fak. za kemijo in kemijsko tehnologijo, smer Biokemija | 
        
           
        
           
        
           
        
            | Strani: | 63 str. | 
        
           
        
           
        
           
        
           
        
           
        
           
        
           
        
           
        
          
        
          
        
          
        
         
        
         
        
        
            | ID: | 11392451 |